CareDx Return on Tangible Equity 2013-2024 | CDNA

Current and historical return on tangible equity values for CareDx (CDNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CareDx Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.14B $0.19B -79.11%
2024-06-30 $-0.16B $0.18B -75.99%
2024-03-31 $-0.18B $0.17B -74.92%
2023-12-31 $-0.19B $0.18B -66.73%
2023-09-30 $-0.09B $0.31B -27.40%
2023-06-30 $-0.08B $0.32B -24.67%
2023-03-31 $-0.08B $0.34B -23.14%
2022-12-31 $-0.08B $0.35B -21.43%
2022-09-30 $-0.08B $0.36B -20.46%
2022-06-30 $-0.07B $0.36B -18.56%
2022-03-31 $-0.05B $0.37B -12.87%
2021-12-31 $-0.03B $0.38B -7.84%
2021-09-30 $-0.02B $0.40B -5.38%
2021-06-30 $-0.01B $0.41B -3.29%
2021-03-31 $-0.02B $0.40B -5.98%
2020-12-31 $-0.02B $0.21B -12.56%
2020-09-30 $-0.02B $0.20B -18.34%
2020-06-30 $-0.02B $0.19B -28.07%
2020-03-31 $-0.02B $0.03B -71.79%
2019-12-31 $-0.02B $0.03B -68.15%
2019-09-30 $-0.02B $0.03B -56.41%
2019-06-30 $-0.04B $0.03B -100.00%
2019-03-31 $-0.05B $0.05B -157.26%
2018-12-31 $-0.05B $0.05B -348.15%
2018-09-30 $-0.08B $0.03B 625.00%
2018-06-30 $-0.07B $-0.02B 219.05%
2018-03-31 $-0.06B $-0.01B 166.20%
2017-12-31 $-0.06B $-0.05B 139.13%
2017-09-30 $-0.04B $-0.05B 113.87%
2017-06-30 $-0.03B $-0.03B 98.31%
2017-03-31 $-0.04B $-0.03B 120.69%
2016-12-31 $-0.04B $-0.03B 185.71%
2016-09-30 $-0.03B $-0.03B 252.17%
2016-06-30 $-0.03B $-0.03B 2800.00%
2016-03-31 $-0.02B $0.00B -182.61%
2015-12-31 $-0.01B $0.01B -80.00%
2015-09-30 $-0.01B $0.02B -41.56%
2015-06-30 $-0.00B $0.02B -19.05%
2015-03-31 $0.00B $0.02B 0.00%
2014-12-31 $0.00B $0.02B 50.00%
2014-09-30 $0.00B $0.02B 0.00%
2014-06-30 $-0.00B $-0.02B 15.38%
2014-03-31 $-0.00B $-0.02B 50.00%
2013-12-31 $-0.00B $-0.02B 106.67%
Sector Industry Market Cap Revenue
Medical Medical Services $1.183B $0.280B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00